Skip to main navigation

Contact Us
EN

Search:

Search:
- EN

Main navigation

About Us
- Our Company
- Contact Us
Pipeline
- BLU-5937
  - Chronic Cough
  - Chronic Pruritus
- Clinical Trials
Science
- P2X3 Inhibition
- Scientific Publications
Investors & Media

Bellus Health

Investors & Media

Investor Contact

Investor Contact

Investor Contact

Danny Matthews
Director, Investor Relations and Communications
ir@bellushealth.com

Name

Email

Subject

Comments

Leave this field blank

Investors & Media

Investors Home
Press Releases
Events & Presentations
Financial Reports & Other
Stock Information
Corporate Governance
Investor Resources

BELLUS Health Inc.
275 Armand-Frappier Blvd.
Laval, Quebec
Canada H7V 4A7

Tel.: (450) 680-4500
Fax: (450) 680-4501
webinfo@bellushealth.com

Footer Nav

Privacy Policy
Legal Disclaimer
Site Map

© BELLUS Health. All Rights Reserved.